275 related articles for article (PubMed ID: 30128780)
1. In Silico Prediction of Diffusion Interaction Parameter (k
Tomar DS; Singh SK; Li L; Broulidakis MP; Kumar S
Pharm Res; 2018 Aug; 35(10):193. PubMed ID: 30128780
[TBL] [Abstract][Full Text] [Related]
2. In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions.
Tomar DS; Li L; Broulidakis MP; Luksha NG; Burns CT; Singh SK; Kumar S
MAbs; 2017 Apr; 9(3):476-489. PubMed ID: 28125318
[TBL] [Abstract][Full Text] [Related]
3. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
[TBL] [Abstract][Full Text] [Related]
4. Improved Diffusion Interaction Parameter Measurement to Predict the Viscosity of Concentrated mAb Solutions.
Wei Y; Qi W; Maglalang E; Pelegri-O'Day EM; Luong M; Razinkov V; Sloey C
Mol Pharm; 2023 Dec; 20(12):6420-6428. PubMed ID: 37906640
[TBL] [Abstract][Full Text] [Related]
5. Rational optimization of a monoclonal antibody for simultaneous improvements in its solution properties and biological activity.
Kumar S; Roffi K; Tomar DS; Cirelli D; Luksha N; Meyer D; Mitchell J; Allen MJ; Li L
Protein Eng Des Sel; 2018 Jul; 31(7-8):313-325. PubMed ID: 30189027
[TBL] [Abstract][Full Text] [Related]
6. Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects.
Yadav S; Shire SJ; Kalonia DS
J Pharm Sci; 2012 Mar; 101(3):998-1011. PubMed ID: 22113861
[TBL] [Abstract][Full Text] [Related]
7. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations.
Buck PM; Chaudhri A; Kumar S; Singh SK
Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990
[TBL] [Abstract][Full Text] [Related]
8. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
[TBL] [Abstract][Full Text] [Related]
9. Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.
Neergaard MS; Kalonia DS; Parshad H; Nielsen AD; Møller EH; van de Weert M
Eur J Pharm Sci; 2013 Jun; 49(3):400-10. PubMed ID: 23624326
[TBL] [Abstract][Full Text] [Related]
10. Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.
Li L; Kumar S; Buck PM; Burns C; Lavoie J; Singh SK; Warne NW; Nichols P; Luksha N; Boardman D
Pharm Res; 2014 Nov; 31(11):3161-78. PubMed ID: 24906598
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in silico assessment of the developability of a designed monoclonal antibody library.
Wolf Pérez AM; Sormanni P; Andersen JS; Sakhnini LI; Rodriguez-Leon I; Bjelke JR; Gajhede AJ; De Maria L; Otzen DE; Vendruscolo M; Lorenzen N
MAbs; 2019; 11(2):388-400. PubMed ID: 30523762
[TBL] [Abstract][Full Text] [Related]
12. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
[TBL] [Abstract][Full Text] [Related]
13. A single molecular descriptor to predict solution behavior of therapeutic antibodies.
Kingsbury JS; Saini A; Auclair SM; Fu L; Lantz MM; Halloran KT; Calero-Rubio C; Schwenger W; Airiau CY; Zhang J; Gokarn YR
Sci Adv; 2020 Aug; 6(32):eabb0372. PubMed ID: 32923611
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter.
Shimomura T; Sekiguchi M; Honda R; Yamazaki M; Yokoyama M; Uchiyama S
Biol Pharm Bull; 2022; 45(9):1300-1305. PubMed ID: 36047198
[TBL] [Abstract][Full Text] [Related]
15. Biophysical and Sequence-Based Methods for Identifying Monovalent and Bivalent Antibodies with High Colloidal Stability.
Alam ME; Geng SB; Bender C; Ludwig SD; Linden L; Hoet R; Tessier PM
Mol Pharm; 2018 Jan; 15(1):150-163. PubMed ID: 29154550
[TBL] [Abstract][Full Text] [Related]
16. Matching pH values for antibody stabilization and crystallization suggest rationale for accelerated development of biotherapeutic drugs.
Sjuts H; Schreuder H; Engel CK; Bussemer T; Gokarn Y
Drug Dev Res; 2020 May; 81(3):329-337. PubMed ID: 31758731
[TBL] [Abstract][Full Text] [Related]
17. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions.
Pindrus M; Shire SJ; Kelley RF; Demeule B; Wong R; Xu Y; Yadav S
Mol Pharm; 2015 Nov; 12(11):3896-907. PubMed ID: 26407030
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning Applied to Determine the Molecular Descriptors Responsible for the Viscosity Behavior of Concentrated Therapeutic Antibodies.
Lai PK; Fernando A; Cloutier TK; Gokarn Y; Zhang J; Schwenger W; Chari R; Calero-Rubio C; Trout BL
Mol Pharm; 2021 Mar; 18(3):1167-1175. PubMed ID: 33450157
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Low Ionic Strength on Diffusion and Viscosity of Monoclonal Antibodies.
Pindrus MA; Shire SJ; Yadav S; Kalonia DS
Mol Pharm; 2018 Aug; 15(8):3133-3142. PubMed ID: 29996057
[TBL] [Abstract][Full Text] [Related]
20. Reduction of monoclonal antibody viscosity using interpretable machine learning.
Makowski EK; Chen HT; Wang T; Wu L; Huang J; Mock M; Underhill P; Pelegri-O'Day E; Maglalang E; Winters D; Tessier PM
MAbs; 2024; 16(1):2303781. PubMed ID: 38475982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]